Schedule 13G ownership disclosure
Arbutus Biopharma Corp
Security class unavailable · CUSIP: 03879J100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,497,578
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-20-000423
- Form type
- SC 13G
- Filer
- Arbutus Biopharma Corp
- CIK
- CIK 1447028
- Filed
- Jul 16, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership